Schedule of Segment Reporting Information, by Segment |
The following table presents the segment loss, including significant segment expenses, for the three and six months ended June 30, 2025 and 2024: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | (In thousands) | | | | | | | | | Operating expenses | | | | | | | | Compensation and benefits | $ | 16,032 | | | $ | 13,469 | | | $ | 32,338 | | | $ | 27,929 | | Clinical trial and manufacturing | 18,707 | | | 4,483 | | | 29,680 | | | 7,838 | | Facilities and IT | 6,045 | | | 9,594 | | | 17,793 | | | 16,562 | | Other research and development | 2,815 | | | 945 | | | 4,958 | | | 1,726 | | Other segment(a) | 6,256 | | | 4,413 | | | 13,307 | | | 8,048 | | Total operating expenses | $ | 49,855 | | | $ | 32,904 | | | $ | 98,076 | | | $ | 62,103 | | Operating loss | (49,855) | | | (32,904) | | | (98,076) | | | (62,103) | | | | | | | | | | | | | | | | | | Other income, net | 664 | | | 2,406 | | | 1,866 | | | 4,458 | | | | | | | | | | | | | | | | | | Segment and consolidated net loss | $ | (49,191) | | | $ | (30,498) | | | $ | (96,210) | | | $ | (57,645) | |
| | | | | | (a) | Other segment include professional services, consultants and contractors, travel and entertainment expenses, and general business expenses. |
|